Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prednisone plus rhTPO versus prednisone plus immunoglobulin for newly diagnosed primary immune thrombocytopenia
ChiCTR-IIR-15007523Phase 4Recruiting
- Sponsor
- Ruijin Hospital
- Start
- Oct 2014
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4 trial of prednisone, recombinant human thrombopoietin and polyvalent human immunoglobulin in immune thrombocytopenia (ITP) (2 arms), sponsored by Ruijin Hospital. Primary endpoints: Platelet count, WHO bleeding score and 2 more. Started Oct 2014; status: recruiting.
02
Drugs
prednisonerecombinant human thrombopoietinpolyvalent human immunoglobulin
03
Conditions
immune thrombocytopenia (ITP)
Beyond the preview
Go deeper on ChiCTR-IIR-15007523.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IIR-15007523.